ALDOA Antikörper (AA 1-364)
ALDOA
Reaktivität: Human
WB, ELISA, IF
Wirt: Maus
Monoclonal
3C12-6D11
unconjugated
-
-
Target
Alle ALDOA Antikörper anzeigen
-
ALDOA
(Aldolase A, Fructose-Bisphosphate (ALDOA))
-
Bindungsspezifität
-
AA 1-364
-
Reaktivität
-
Human
-
Wirt
-
Maus
-
Klonalität
-
Monoklonal
-
Konjugat
-
Dieser ALDOA Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), ELISA, Immunofluorescence (IF)
-
Verwendungszweck
-
Mouse monoclonal antibody raised against a full length recombinant ALDOA.
-
Sequenz
-
MPYQYPALTP EQKKELSDIA HRIVAPGKGI LAADESTGSI AKRLQSIGTE NTEENRRFYR QLLLTADDRV NPCIGGVILF HETLYQKADD GRPFPQVIKS KGGVVGIKVD KGVVPLAGTN GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKIGEHTPS ALAIMENANV LARYASICQQ NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HIYLEGTLLK PNMVTPGHAC TQKFSHEEIA MATVTALRRT VPPAVTGITF LSGGQSEEEA SINLNAINKC PLLKPWALTF SYGRALQASA LKAWGGKKEN LKAAQEEYVK RALANSLACQ GKYTPSGQAG AAASESLFVS NHAY
-
Kreuzreaktivität
-
Human
-
Produktmerkmale
-
Antibody Reactive Against Recombinant Protein.
-
Immunogen
-
ALDOA (AAH10660.1, 1 a.a. ~ 364 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Klon
-
3C12-6D11
-
Isotyp
-
IgG1
-
Top Product
-
Discover our top product ALDOA Primärantikörper
-
-
-
Applikationshinweise
-
Optimal working dilution should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Buffer
-
In 1x PBS, pH 7.4
-
Handhabung
-
Aliquot to avoid repeated freezing and thawing.
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Perroud, Ishimaru, Borowsky, Weiss: "Grade-dependent proteomics characterization of kidney cancer." in: Molecular & cellular proteomics : MCP, Vol. 8, Issue 5, pp. 971-85, (2009) (PubMed).
-
-
Target
-
ALDOA
(Aldolase A, Fructose-Bisphosphate (ALDOA))
-
Andere Bezeichnung
-
ALDOA (ALDOA Produkte)
-
Hintergrund
-
Full Gene Name: aldolase A, fructose-bisphosphate
Synonyms: ALDA,MGC10942,MGC17716,MGC17767
-
Gen-ID
-
226
-
Pathways
-
Ribonucleoside Biosynthetic Process
-